US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

26.43

-0.2200-0.83%

Post-market: 26.430.00000.00%19:30 EDT

Volume:633.05K

Turnover:16.89M

Market Cap:1.46B

PE:-10.50

High:27.49

Open:27.08

Low:26.36

Close:26.65

52wk High:53.65

52wk Low:21.95

Shares:55.25M

Float Shares:37.25M

Volume Ratio:0.81

T/O Rate:1.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5172

EPS(LYR):-3.0510

ROE:-37.35%

ROA:-21.79%

PB:3.22

PE(LYR):-8.66

Loading ...

Overview Company News Filings

Maze Therapeutics CSBO Atul Dandekar Disposes of 7,500 Common Shares Worth $202,920.75

Maze Therapeutics Rises After Citi Initiates with 'buy'

Maze Therapeutics initiated with a Buy at Citi

Maze Therapeutics up over 21%, on Pace for Largest Percent Increase Since September 2025

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of 9,705 Common Shares for $254,543

Maze Therapeutics President, R&D and CMO Harold Bernstein Sells 16,141 Common Shares Worth $425,392.65

Maze Therapeutics to Participate in Three Upcoming Investor Conferences

Maze Therapeutics CSBO Atul Dandekar Disposes of Common Shares Worth $206,823.75

Press Release: MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update

Maze Therapeutics Director Paula A. Johnson Files Initial Beneficial Ownership Statement

Maze Therapeutics Names Paula Johnson, Sophie Kornowski to Board of Directors

Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of USD 445,522 Common Shares

Maze Therapeutics Adds Paula Johnson, Sophie Kornowski to Board

Maze Therapeutics Announces Appointments to Its Board of Directors

THOMSON REUTERS

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Legal and Regulatory Risks Threaten Maze Therapeutics’ Funding, Reputation and Path to Commercialization

Belite Bio Q2 Net Loss Widens on Higher Expenses

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

Humacyte Q2 Net Loss Widens on Inventory, Production Costs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/MAZE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":26.43,"timestamp":1790971200000,"preClose":26.65,"halted":0,"volume":633045,"hourTrading":{"tag":"盘后","latestPrice":26.43,"preClose":26.43,"latestTime":"19:30 EDT","volume":10399,"amount":274845.57,"timestamp":1790983804073,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008255159474671628,"floatShares":37250300,"shares":55248700,"eps":-2.517242,"marketStatus":"Market Closed","change":-0.22,"latestTime":"10-02 16:00:00 EDT","open":27.08,"high":27.49,"low":26.36,"amount":16886048.70267,"amplitude":0.042402,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.517242,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":26.65,"preHourTrading":{"tag":"盘前","latestPrice":27.09,"preClose":26.65,"latestTime":"09:29 EDT","volume":286,"amount":7746.50019,"timestamp":1790947799999,"change":0.44,"changeRate":0.01651,"amplitude":0.046529},"postHourTrading":{"tag":"盘后","latestPrice":26.43,"preClose":26.43,"latestTime":"19:30 EDT","volume":10399,"amount":274845.57,"timestamp":1790983804073,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8074940838999421,"impliedVol":1.455,"impliedVolPercentile":0.9124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":37250300,"roa":"-21.79%","roe":"-37.35%","lyrEps":-3.051003,"volumeRatio":0.8074940838999421,"shares":55248700,"dividePrice":0,"high":27.49,"amplitude":0.042402,"preClose":26.65,"low":26.36,"week52Low":21.95,"pbRate":"3.22","psRate":"73.01","week52High":53.65,"institutionHeld":0,"latestPrice":26.43,"eps":-2.517242,"divideRate":0,"volume":633045,"delay":0,"ttmEps":-2.517242,"open":27.08,"prevYearClose":41.43,"prevWeekClose":26.05,"prevMonthClose":27.18,"prevQuarterClose":27.18,"fiveDayClose":26.05,"twentyDayClose":25.87,"sixtyDayClose":32.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MAZE","fiscalQuarterEnding":"2026/06","expectedEps":-0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2026-05-12","symbol":"MAZE","fiscalQuarterEnding":"2026/03","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2026-03-25","symbol":"MAZE","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-11-06","symbol":"MAZE","fiscalQuarterEnding":"2025/09","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-08-12","symbol":"MAZE","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.5385,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1790222400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2026-10-01","current":-10.499586,"percent":0.399522,"low":-19.775245,"twenty":-14.158477,"median":-10.762812,"eighty":9.00245,"high":14.99285,"avg":-5.264865,"sd":10.833837,"marketCap":1509826386},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-25","current":6.456504,"twenty":7.783022,"median":9.224877,"eighty":9.897831,"marketCap":337229638},{"date":"2025-05-02","current":8.879789,"twenty":7.580103,"median":8.972089,"eighty":9.731387,"marketCap":463800243},{"date":"2025-05-09","current":8.40184,"twenty":7.63209,"median":8.956237,"eighty":9.655299,"marketCap":438836491},{"date":"2025-05-16","current":7.799992,"twenty":7.63958,"median":8.89283,"eighty":9.626766,"marketCap":405123785},{"date":"2025-05-23","current":8.575775,"twenty":7.65241,"median":8.850167,"eighty":9.590307,"marketCap":445417178},{"date":"2025-05-30","current":10.26226,"twenty":7.715941,"median":8.87535,"eighty":9.631522,"marketCap":533011510},{"date":"2025-06-06","current":11.248853,"twenty":7.782471,"median":8.89283,"eighty":9.769431,"marketCap":584254194},{"date":"2025-06-13","current":11.425934,"twenty":7.799992,"median":8.956237,"eighty":10.149874,"marketCap":593451599},{"date":"2025-06-20","current":9.494909,"twenty":7.805949,"median":9.034945,"eighty":10.238649,"marketCap":493156089},{"date":"2025-06-27","current":10.742908,"twenty":7.871903,"median":9.097801,"eighty":10.238649,"marketCap":557975894},{"date":"2025-07-03","current":9.697287,"twenty":7.967493,"median":9.217791,"eighty":10.255514,"marketCap":503667409},{"date":"2025-07-11","current":13.188311,"twenty":8.01948,"median":9.285161,"eighty":10.297295,"marketCap":684987676},{"date":"2025-07-18","current":14.385715,"twenty":8.08904,"median":9.384234,"eighty":10.584212,"marketCap":747179651},{"date":"2025-07-25","current":13.871337,"twenty":8.197097,"median":9.417731,"eighty":10.84241,"marketCap":720463380},{"date":"2025-08-01","current":12.437825,"twenty":8.267679,"median":9.479345,"eighty":11.289329,"marketCap":646008198},{"date":"2025-08-08","current":11.231989,"twenty":8.274387,"median":9.503122,"eighty":11.660356,"marketCap":583378251},{"date":"2025-08-15","current":-4.846264,"twenty":8.197097,"median":9.495197,"eighty":11.50014,"marketCap":585409301},{"date":"2025-08-22","current":-4.802702,"twenty":7.843394,"median":9.46183,"eighty":11.412442,"marketCap":580147195},{"date":"2025-08-29","current":-5.180239,"twenty":7.675693,"median":9.408012,"eighty":11.34667,"marketCap":625752114},{"date":"2025-09-05","current":-5.459761,"twenty":7.605258,"median":9.384234,"eighty":11.299448,"marketCap":659517295},{"date":"2025-09-12","current":-9.002797,"twenty":7.051844,"median":9.285161,"eighty":11.248853,"marketCap":1087501923},{"date":"2025-09-19","current":-8.523616,"twenty":6.791906,"median":9.217791,"eighty":11.231989,"marketCap":1029618756},{"date":"2025-09-26","current":-9.565472,"twenty":6.372653,"median":9.072896,"eighty":11.223556,"marketCap":1155470793},{"date":"2025-10-03","current":-9.619925,"twenty":-4.846264,"median":8.956237,"eighty":11.080205,"marketCap":1162048426},{"date":"2025-10-10","current":-10.440341,"twenty":-4.897086,"median":8.912645,"eighty":10.903124,"marketCap":1261151423},{"date":"2025-10-17","current":-10.327806,"twenty":-5.035032,"median":8.87091,"eighty":10.852529,"marketCap":1247557649},{"date":"2025-10-24","current":-10.854179,"twenty":-5.43435,"median":8.743704,"eighty":10.801935,"marketCap":1311141431},{"date":"2025-10-31","current":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"marketCap":1456726366},{"date":"2025-11-07","current":-10.301208,"twenty":-8.440123,"median":8.622163,"eighty":10.742908,"marketCap":1299301692},{"date":"2025-11-14","current":-12.147078,"twenty":-8.530877,"median":8.52824,"eighty":10.604819,"marketCap":1532123096},{"date":"2025-11-21","current":-13.570087,"twenty":-9.148004,"median":8.467465,"eighty":10.501783,"marketCap":1711608623},{"date":"2025-11-28","current":-14.401765,"twenty":-9.516102,"median":8.389744,"eighty":10.458575,"marketCap":1816509011},{"date":"2025-12-05","current":-16.252058,"twenty":-9.864597,"median":8.267679,"eighty":10.366822,"marketCap":2049888314},{"date":"2025-12-12","current":-15.096102,"twenty":-10.151143,"median":8.122944,"eighty":10.312226,"marketCap":1904086399},{"date":"2025-12-19","current":-15.496681,"twenty":-10.373183,"median":7.957431,"eighty":10.278273,"marketCap":1954611815},{"date":"2025-12-26","current":-16.053676,"twenty":-10.591356,"median":7.799992,"eighty":10.266129,"marketCap":2024866203},{"date":"2026-01-02","current":-15.805699,"twenty":-10.832398,"median":7.756189,"eighty":10.248768,"marketCap":1993588564},{"date":"2026-01-09","current":-14.859569,"twenty":-11.164921,"median":7.639287,"eighty":10.225157,"marketCap":1874252343},{"date":"2026-01-16","current":-15.187663,"twenty":-11.722514,"median":7.479482,"eighty":10.213352,"marketCap":1915635065},{"date":"2026-01-23","current":-17.625471,"twenty":-12.065201,"median":7.127309,"eighty":10.196366,"marketCap":2223118312},{"date":"2026-01-30","current":-17.167667,"twenty":-12.419472,"median":6.955415,"eighty":10.162555,"marketCap":2165374980},{"date":"2026-02-06","current":-16.767088,"twenty":-13.567798,"median":6.791906,"eighty":10.126096,"marketCap":2114849563},{"date":"2026-02-13","current":-17.945934,"twenty":-14.175152,"median":6.511006,"eighty":10.056348,"marketCap":2263538645},{"date":"2026-02-20","current":-17.182927,"twenty":-14.401765,"median":6.360075,"eighty":9.954897,"marketCap":2167299757},{"date":"2026-02-27","current":-17.48813,"twenty":-14.737488,"median":-4.831743,"eighty":9.883564,"marketCap":2205795312},{"date":"2026-03-06","current":-17.282118,"twenty":-15.149512,"median":-4.864415,"eighty":9.832206,"marketCap":2179810813},{"date":"2026-03-13","current":-19.775245,"twenty":-15.332634,"median":-4.897086,"eighty":9.697287,"marketCap":2494271379},{"date":"2026-03-20","current":-18.857728,"twenty":-15.469975,"median":-4.962429,"eighty":9.697287,"marketCap":2378544116},{"date":"2026-03-27","current":-12.021519,"twenty":-15.550091,"median":-5.100375,"eighty":9.693343,"marketCap":1576261545},{"date":"2026-04-02","current":-11.013091,"twenty":-15.507363,"median":-5.260102,"eighty":9.683007,"marketCap":1444036514},{"date":"2026-04-10","current":-10.569535,"twenty":-15.475316,"median":-5.486987,"eighty":9.652715,"marketCap":1385877385},{"date":"2026-04-17","current":-10.186635,"twenty":-15.415039,"median":-5.764695,"eighty":9.626766,"marketCap":1335671640},{"date":"2026-04-24","current":-10.959561,"twenty":-15.395201,"median":-7.129635,"eighty":9.621519,"marketCap":1437017594},{"date":"2026-05-01","current":-11.209856,"twenty":-15.384518,"median":-8.456458,"eighty":9.590184,"marketCap":1469836362},{"date":"2026-05-08","current":-10.741725,"twenty":-15.342553,"median":-8.527247,"eighty":9.573739,"marketCap":1408454934},{"date":"2026-05-15","current":-11.93693,"twenty":-15.289905,"median":-9.002797,"eighty":9.561199,"marketCap":1462775248},{"date":"2026-05-22","current":-11.629812,"twenty":-15.205975,"median":-9.258724,"eighty":9.520559,"marketCap":1425140470},{"date":"2026-05-29","current":-11.92338,"twenty":-15.178506,"median":-9.458383,"eighty":9.511048,"marketCap":1461114890},{"date":"2026-06-05","current":-11.471737,"twenty":-15.158668,"median":-9.619925,"eighty":9.501537,"marketCap":1405769629},{"date":"2026-06-12","current":-10.880085,"twenty":-15.117466,"median":-9.821399,"eighty":9.495024,"marketCap":1333267337},{"date":"2026-06-18","current":-11.218817,"twenty":-15.001489,"median":-9.973866,"eighty":9.488683,"marketCap":1374776283},{"date":"2026-06-26","current":-12.203399,"twenty":-14.845835,"median":-10.113627,"eighty":9.465333,"marketCap":1495428952},{"date":"2026-07-02","current":-13.463484,"twenty":-14.807685,"median":-10.175262,"eighty":9.440942,"marketCap":1649842230},{"date":"2026-07-10","current":-14.642273,"twenty":-14.807685,"median":-10.243922,"eighty":9.423562,"marketCap":1794293361},{"date":"2026-07-17","current":-12.268888,"twenty":-14.735962,"median":-10.345957,"eighty":9.406427,"marketCap":1503454015},{"date":"2026-07-24","current":-12.506,"twenty":-14.713835,"median":-10.387794,"eighty":9.396916,"marketCap":1532510277},{"date":"2026-07-31","current":-12.478902,"twenty":-14.649742,"median":-10.467027,"eighty":9.384234,"marketCap":1529189561},{"date":"2026-08-07","current":-12.88538,"twenty":-14.642273,"median":-10.571027,"eighty":9.336679,"marketCap":1579000296},{"date":"2026-08-14","current":-11.503614,"twenty":-14.638297,"median":-10.649147,"eighty":9.29705,"marketCap":1536767732},{"date":"2026-08-21","current":-12.029624,"twenty":-14.610658,"median":-10.685878,"eighty":9.273272,"marketCap":1607037430},{"date":"2026-08-28","current":-11.892404,"twenty":-14.448066,"median":-10.740929,"eighty":9.231962,"marketCap":1588706204},{"date":"2026-09-04","current":-10.75722,"twenty":-14.401765,"median":-10.762812,"eighty":9.217791,"marketCap":1437056976},{"date":"2026-09-11","current":-10.32061,"twenty":-14.401765,"median":-10.762812,"eighty":9.129021,"marketCap":1378730349},{"date":"2026-09-18","current":-9.746781,"twenty":-14.355984,"median":-10.740929,"eighty":9.099607,"marketCap":1302072497},{"date":"2026-09-25","current":-10.898598,"twenty":-14.243822,"median":-10.741725,"eighty":9.057953,"marketCap":1455943693},{"date":"2026-10-01","current":-11.301942,"twenty":-14.158477,"median":-10.762812,"eighty":9.00245,"marketCap":1509826386}],"updateTime":1790994257293},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672764185","title":"Maze Therapeutics CSBO Atul Dandekar Disposes of 7,500 Common Shares Worth $202,920.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764185","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764185?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:07","pubTimestamp":1790885254,"startTime":"0","endTime":"0","summary":"Maze Therapeutics CSBO Atul Dandekar disposes of 7,500 common shares worth $202,920.75Maze Therapeutics CSBO Atul Dandekar exercised stock options for 7,500 shares at USD 10.42 on Sept. 29, 2026.He so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL40cPjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics CSBO Atul Dandekar Disposes of 7,500 Common Shares Worth $202,920.75","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488852","title":"Maze Therapeutics Rises After Citi Initiates with 'buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488852?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:16","pubTimestamp":1790162183,"startTime":"0","endTime":"0","summary":"BUZZ-Maze Therapeutics rises after Citi initiates with 'buy'** Shares of biotech firm Maze TherapeuticsMAZE.Orise 1.5% to $28.8 premarket** Brokerage Citi initiates coverage with \"buy\" and a $50 PT, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F0K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104282","title":"Maze Therapeutics initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669104282?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:20","pubTimestamp":1790155214,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of Maze Therapeutics (MAZE) with a Buy rating and $50 price target The firm sees the company’s APOL1-mediated kidney diseas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","MAZE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669712668","title":"Maze Therapeutics up over 21%, on Pace for Largest Percent Increase Since September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2669712668","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669712668?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:50","pubTimestamp":1790095800,"startTime":"0","endTime":"0","summary":"Maze Therapeutics, Inc.  is currently at $27.23, up $4.84 or 21.62%--Would be highest close since Aug. 28, 2026, when it closed at $27.44--On pace for largest percent increase since Sept. 11, 2025, when it rose 54.81%--Snaps a five day losing streak--Up 2.48% month-to-date--Down 34.27% year-to-date--Down 47.47% from its all-time closing high of $51.84 on March 12, 2026--Up 9.45% from 52 weeks ago , when it closed at $24.88--Down 47.47% from its 52-week closing high of $51.84 on March 12, 2026--Up 21.62% from its 52-week closing low of $22.39 on Sept. 21, 2026--Traded as high as $29.40; highest intraday level since Aug. 26, 2026, when it hit $30.40--Up 31.31% at today's intraday high; largest intraday percent increase since Sept. 11, 2025, when it rose as much as 59.18%All data as of 12:44:05 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Maze Therapeutics up over 21%, on Pace for Largest Percent Increase Since September 2025","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4539","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1069344957.HKD","LU2462157665.USD","IDNA","LU1035775433.USD","IE0009355771.USD","LU2324357040.USD","MAZE","LU0234570918.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1778281490.HKD","LU1674673428.USD","LU0889565916.HKD","BK4023","GNMX","IE00B894F039.SGD","LU0256863811.USD","LU1430594728.SGD","LU1815336091.USD","BK4532","PBE","LU2456880835.USD","BK4588","BK4567","LU1559883803.SGD","LU2362541513.USD","IBBQ","LU2237438978.USD","IE00BZ9MQY76.HKD","LU1093756168.USD","LU0058720904.USD","BIB","IE00B19Z9Z06.USD","XBI","LU0079474960.USD","VRTX","LU1585245621.USD","BBH","LU0432979614.USD","IE00BFTCPJ56.SGD","VERX","LU0289739699.SGD","LU2236285917.USD","IE00B19Z3581.USD","BK4585","IBB","LU2089984988.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377654","title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of 9,705 Common Shares for $254,543","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377654","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377654?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:21","pubTimestamp":1788898887,"startTime":"0","endTime":"0","summary":"Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of 9,705 common shares for $254,543Harold Bernstein, President, R&D & CMO, sold 9,705 shares of Maze Therapeutics common stock on Sep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3v02SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of 9,705 Common Shares for $254,543","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801180","title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Sells 16,141 Common Shares Worth $425,392.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801180","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801180?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:24","pubTimestamp":1788467093,"startTime":"0","endTime":"0","summary":"Maze Therapeutics President, R&D and CMO Harold Bernstein sells 16,141 common shares worth $425,392.65Harold Bernstein, President, R&D & CMO, reported a same-day exercise and sale in Maze Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL66dvcM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Sells 16,141 Common Shares Worth $425,392.65","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815092","title":"Maze Therapeutics to Participate in Three Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815092","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815092?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for pa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354981/0/en/maze-therapeutics-to-participate-in-three-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885024","title":"Maze Therapeutics CSBO Atul Dandekar Disposes of Common Shares Worth $206,823.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885024","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885024?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:33","pubTimestamp":1788215589,"startTime":"0","endTime":"0","summary":"Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $206,823.75Maze Therapeutics CSBO Atul Dandekar sold 7,500 common shares on Aug. 28, 2026 at USD 27.58.The sale followed the exerci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLJqTrc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics CSBO Atul Dandekar Disposes of Common Shares Worth $206,823.75","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778685","title":"Press Release: MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778685","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778685?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:33","pubTimestamp":1787808780,"startTime":"0","endTime":"0","summary":"GENEVA, Aug. 27, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA  , a global leader in scalable precision neurotherapeutics, today announced the publication of its 2026 half-year report and provided a corporate update.Key Highlights-- Expanded U.S. commercial capabilities and reach through the build-out of. the Company's commercial organization, continued development of its. customer pipeline, and a channel partnership with Vibra Healthcare.-- Compelling real-world evidence from a two-year, multi-site program. -- Advanced its European reimbursement strategy with first patient. enrollment in SwissNeuroRehab and launch of the REACT-AVC study in. -- Expanded the clinical application of the platform through support for a. University of Pittsburgh study pairing spinal cord stimulation with. -- Completed organizational simplification, including the disposal of. non-neurology legacy operations, resulting in a focused organization and. -- Received CHF 4.0 million under a CHF 8.0 million ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660324524","title":"Maze Therapeutics Director Paula A. Johnson Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660324524","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660324524?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:46","pubTimestamp":1786999574,"startTime":"0","endTime":"0","summary":"Maze Therapeutics director Paula A. Johnson files initial beneficial ownership statementMaze Therapeutics director Paula A. Johnson filed an initial Form 3 on Aug. 17, 2026.Disclaimer:This news brief ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL78z2DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660328084","title":"Maze Therapeutics Names Paula Johnson, Sophie Kornowski to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660328084","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660328084?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:18","pubTimestamp":1786997890,"startTime":"0","endTime":"0","summary":"Maze Therapeutics names Paula Johnson, Sophie Kornowski to board of directorsMaze Therapeutics named Paula Johnson and Sophie Kornowski to its board of directors.Johnson is president of Wellesley Coll","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL87kkJn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659712190","title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of USD 445,522 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659712190","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659712190?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:58","pubTimestamp":1786741080,"startTime":"0","endTime":"0","summary":"Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common sharesMaze Therapeutics President, R&D and CMO Harold Bernstein sold 16,142 common shares on Aug. 13 at USD 27.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3LPRJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics President, R&D and CMO Harold Bernstein Disposes of USD 445,522 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614160","title":"Maze Therapeutics Adds Paula Johnson, Sophie Kornowski to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614160","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:49","pubTimestamp":1786654155,"startTime":"0","endTime":"0","summary":"Maze Therapeutics adds Paula Johnson, Sophie Kornowski to boardMaze Therapeutics appointed Paula Johnson and Sophie Kornowski to its board.Johnson is president of Wellesley College, a cardiologist, an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL7LTtBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0345769128.USD","LU1221951046.USD","LU0787776722.HKD","GDOC","VHT","LU2456880835.USD","MAZE","BCDF","LU2112291526.USD","IE00BZ1G4Q59.USD","FTXH","BK4585","LU1894683348.USD","LU0689626769.HKD","PJP","LU0820561818.USD","LU1732800096.USD","LU0985320562.USD","RXL","LU1244550494.USD","IXJ","LU2471134523.USD","JNJ","IE00BJT1NW94.SGD","LU0320765646.SGD","SGXZ80539844.SGD","IYH","IE00BKPKM429.USD","IE00BSNM7G36.USD","LU0345770993.USD","LU0689472784.USD","LU0820562030.AUD","LU1778281490.HKD","MEDX","LU1043141123.HKD","LU0820561909.HKD","BK4534","BMED","IE00BVYPNW00.USD","IE000SO60NU8.SGD","IE00BGHQF631.EUR","LU2129689431.USD","IHE","JDOC","XLV","TRUH","LU1066051811.HKD","LU0964807845.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659351160","title":"Maze Therapeutics Announces Appointments to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659351160","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659351160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:42","pubTimestamp":1786653745,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUABH5JRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659675701","title":"CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2659675701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659675701?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:22","pubTimestamp":1786652530,"startTime":"0","endTime":"0","summary":"CAMP4 Therapeutics Q2 loss per share misses estimates on non-cash derivative chargeOverviewUS biopharmaceutical developer's Q2 loss per share missed analyst expectationsNet loss widened due to non-cas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","ABEO","CAMP","MAZE","BK4007","BK4020","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659713511","title":"Legal and Regulatory Risks Threaten Maze Therapeutics’ Funding, Reputation and Path to Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659713511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659713511?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:00","pubTimestamp":1786600849,"startTime":"0","endTime":"0","summary":"Maze Therapeutics, Inc. (MAZE) has disclosed a new risk, in the Regulation category. Maze Therapeutics, Inc. faces a material risk that future liti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legal-and-regulatory-risks-threaten-maze-therapeutics-funding-reputation-and-path-to-commercialization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legal-and-regulatory-risks-threaten-maze-therapeutics-funding-reputation-and-path-to-commercialization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659823201","title":"Belite Bio Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2659823201","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659823201?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:55","pubTimestamp":1786586157,"startTime":"0","endTime":"0","summary":"Belite Bio Q2 net loss widens on higher expensesOverviewUS retinal disease drug developer's Q2 net loss widened as R&D and SG&A expenses increasedFDA accepted NDA for tinlarebant with Priority Review ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A01Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","MAZE","BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974286","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974286?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Maze Therapeutics, Inc....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","BK4137","IMNM","MAZE","LU0029874061.USD","BK4588","BK4581","BK4585","BK4139","LFSC","BK4007","HCSG","LABU","LU0128526141.USD","XBI","TVTX","XLV","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971411","title":"Humacyte Q2 Net Loss Widens on Inventory, Production Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971411","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971411?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:11","pubTimestamp":1786533109,"startTime":"0","endTime":"0","summary":"Humacyte Q2 net loss widens on inventory, production costsOverviewU.S. bioengineered tissue maker's Q2 net loss widened, missing analyst expectationsQ2 product revenue for Symvess rose to $0.4 mln fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PLRX","HUMA","PROK","MAZE","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}]}}